Feng, Z., Li, K., Wu, Y., & Peng, C. (2021). Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. Front Mol Biosci.
Styl ChicagoFeng, Zengyu, Kexian Li, Yulian Wu, a Chenghong Peng. "Transcriptomic Profiling Identifies DCBLD2 As a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma." Front Mol Biosci 2021.
Citace podle MLAFeng, Zengyu, Kexian Li, Yulian Wu, a Chenghong Peng. "Transcriptomic Profiling Identifies DCBLD2 As a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma." Front Mol Biosci 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..